annual cash & cash equivalents:
$20.07B-$571.00M(-2.77%)Summary
- As of today (May 29, 2025), MET annual cash & cash equivalents is $20.07 billion, with the most recent change of -$571.00 million (-2.77%) on December 31, 2024.
- During the last 3 years, MET annual cash & cash equivalents has risen by +$21.00 million (+0.10%).
- MET annual cash & cash equivalents is now -17.10% below its all-time high of $24.21 billion, reached on December 31, 2008.
Performance
MET Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$21.33B+$1.26B(+6.27%)Summary
- As of today (May 29, 2025), MET quarterly cash & cash equivalents is $21.33 billion, with the most recent change of +$1.26 billion (+6.27%) on March 31, 2025.
- Over the past year, MET quarterly cash & cash equivalents has increased by +$1.49 billion (+7.49%).
- MET quarterly cash & cash equivalents is now -14.82% below its all-time high of $25.04 billion, reached on June 30, 2021.
Performance
MET quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
MET Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -2.8% | +7.5% |
| 3 y3 years | +0.1% | -9.2% |
| 5 y5 years | +20.9% | -11.5% |
MET Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -2.8% | +0.1% | -9.2% | +43.0% |
| 5 y | 5-year | -2.8% | +20.9% | -14.8% | +43.0% |
| alltime | all time | -17.1% | +182.4% | -14.8% | +1232.9% |
MET Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $21.33B(+6.3%) |
| Dec 2024 | $20.07B(-2.8%) | $20.07B(-7.8%) |
| Sep 2024 | - | $21.77B(+4.7%) |
| Jun 2024 | - | $20.79B(+4.8%) |
| Mar 2024 | - | $19.84B(-3.9%) |
| Dec 2023 | $20.64B(+2.2%) | $20.64B(+38.4%) |
| Sep 2023 | - | $14.91B(-3.3%) |
| Jun 2023 | - | $15.42B(-16.5%) |
| Mar 2023 | - | $18.46B(-8.6%) |
| Dec 2022 | $20.20B(+0.7%) | $20.20B(-9.0%) |
| Sep 2022 | - | $22.20B(+8.0%) |
| Jun 2022 | - | $20.55B(-12.5%) |
| Mar 2022 | - | $23.49B(+17.2%) |
| Dec 2021 | $20.05B(+1.3%) | $20.05B(+5.8%) |
| Sep 2021 | - | $18.96B(-24.3%) |
| Jun 2021 | - | $25.04B(+27.5%) |
| Mar 2021 | - | $19.64B(-0.8%) |
| Dec 2020 | $19.80B(+19.3%) | $19.80B(-18.9%) |
| Sep 2020 | - | $24.41B(+0.5%) |
| Jun 2020 | - | $24.29B(+0.8%) |
| Mar 2020 | - | $24.09B(+45.2%) |
| Dec 2019 | $16.60B(+4.9%) | $16.60B(-14.7%) |
| Sep 2019 | - | $19.45B(+5.5%) |
| Jun 2019 | - | $18.43B(+27.1%) |
| Mar 2019 | - | $14.51B(-8.3%) |
| Dec 2018 | $15.82B(+24.6%) | $15.82B(+26.7%) |
| Sep 2018 | - | $12.49B(-23.4%) |
| Jun 2018 | - | $16.31B(+17.1%) |
| Mar 2018 | - | $13.93B(+9.7%) |
| Dec 2017 | $12.70B(+0.4%) | $12.70B(-2.5%) |
| Sep 2017 | - | $13.02B(-24.8%) |
| Jun 2017 | - | $17.32B(-0.5%) |
| Mar 2017 | - | $17.41B(+37.6%) |
| Dec 2016 | $12.65B(-0.8%) | $12.65B(-20.3%) |
| Sep 2016 | - | $15.88B(-6.9%) |
| Jun 2016 | - | $17.07B(+28.4%) |
| Mar 2016 | - | $13.29B(+4.2%) |
| Dec 2015 | $12.75B(+18.0%) | $12.75B(+24.8%) |
| Sep 2015 | - | $10.22B(+26.5%) |
| Jun 2015 | - | $8.07B(-0.7%) |
| Mar 2015 | - | $8.13B(-24.8%) |
| Dec 2014 | $10.81B(+42.5%) | $10.81B(+23.1%) |
| Sep 2014 | - | $8.78B(+18.8%) |
| Jun 2014 | - | $7.39B(-13.8%) |
| Mar 2014 | - | $8.57B(+13.0%) |
| Dec 2013 | $7.58B | $7.58B(-33.3%) |
| Sep 2013 | - | $11.38B(+23.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2013 | - | $9.18B(-8.0%) |
| Mar 2013 | - | $9.98B(-36.6%) |
| Dec 2012 | $15.74B(+50.4%) | $15.74B(-7.2%) |
| Sep 2012 | - | $16.95B(+5.7%) |
| Jun 2012 | - | $16.04B(-14.1%) |
| Mar 2012 | - | $18.67B(+78.4%) |
| Dec 2011 | $10.46B(-19.8%) | $10.46B(+4.6%) |
| Sep 2011 | - | $10.00B(+3.9%) |
| Jun 2011 | - | $9.63B(-10.0%) |
| Mar 2011 | - | $10.69B(-18.0%) |
| Dec 2010 | $13.05B(+29.0%) | $13.05B(+21.9%) |
| Jun 2010 | - | $10.70B(+16.3%) |
| Mar 2010 | - | $9.20B(-9.0%) |
| Dec 2009 | $10.11B(-58.2%) | $10.11B(-35.0%) |
| Sep 2009 | - | $15.56B(+17.8%) |
| Jun 2009 | - | $13.21B(-32.0%) |
| Mar 2009 | - | $19.42B(-19.8%) |
| Dec 2008 | $24.21B(+143.0%) | $24.21B(+19.8%) |
| Sep 2008 | - | $20.21B(+46.3%) |
| Jun 2008 | - | $13.81B(+27.0%) |
| Mar 2008 | - | $10.87B(+9.2%) |
| Dec 2007 | $9.96B(+40.2%) | $9.96B(+15.5%) |
| Sep 2007 | - | $8.63B(+32.6%) |
| Jun 2007 | - | $6.50B(-0.6%) |
| Mar 2007 | - | $6.54B(-7.9%) |
| Dec 2006 | $7.11B | $7.11B(+20.0%) |
| Sep 2006 | - | $5.92B(+43.6%) |
| Jun 2006 | - | $4.13B(-19.8%) |
| Mar 2006 | - | $5.14B(-26.0%) |
| Sep 2005 | - | $6.95B(-48.9%) |
| Jun 2005 | - | $13.61B(+246.7%) |
| Mar 2005 | - | $3.92B(+9.3%) |
| Sep 2004 | - | $3.59B(-19.4%) |
| Jun 2004 | - | $4.46B(+41.7%) |
| Mar 2004 | - | $3.15B(-41.4%) |
| Sep 2003 | - | $5.37B(-6.0%) |
| Jun 2003 | - | $5.71B(+15.7%) |
| Mar 2003 | - | $4.94B(+35.4%) |
| Sep 2002 | - | $3.65B(+2.4%) |
| Jun 2002 | - | $3.56B(-11.5%) |
| Mar 2002 | - | $4.02B(-9.5%) |
| Sep 2001 | - | $4.45B(-6.4%) |
| Jun 2001 | - | $4.75B(+12.9%) |
| Mar 2001 | - | $4.21B(+162.8%) |
| Sep 2000 | - | $1.60B(-49.8%) |
| Jun 2000 | - | $3.19B(+42.5%) |
| Mar 2000 | - | $2.24B |
FAQ
- What is MetLife annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for MetLife?
- What is MetLife annual cash & cash equivalents year-on-year change?
- What is MetLife quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for MetLife?
- What is MetLife quarterly cash & cash equivalents year-on-year change?
What is MetLife annual cash & cash equivalents?
The current annual cash & cash equivalents of MET is $20.07B
What is the all time high annual cash & cash equivalents for MetLife?
MetLife all-time high annual cash & cash equivalents is $24.21B
What is MetLife annual cash & cash equivalents year-on-year change?
Over the past year, MET annual cash & cash equivalents has changed by -$571.00M (-2.77%)
What is MetLife quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of MET is $21.33B
What is the all time high quarterly cash & cash equivalents for MetLife?
MetLife all-time high quarterly cash & cash equivalents is $25.04B
What is MetLife quarterly cash & cash equivalents year-on-year change?
Over the past year, MET quarterly cash & cash equivalents has changed by +$1.49B (+7.49%)